NEW
YORK, July 15, 2024 /PRNewswire/ -- The
global proteomics market size is estimated to grow by
USD 33.99 billion from
2024-2028, according to Technavio. The market is estimated to grow
at a CAGR of almost 16.83% during the forecast period.
Increasing advances in proteomics research is driving market
growth, with a trend towards growing focus on monitoring
PTMS. However, shortage of trained laboratory professionals
poses a challenge. Key market players include Agilent
Technologies Inc., Applied Biomics Inc., Bio Rad Laboratories Inc.,
Biognosys AG, Bruker Corp., Cell Signaling Technology Inc.,
CellCarta Biosciences Inc., Creative Proteomics, DiaSorin Spa, F.
Hoffmann La Roche Ltd., Geno Technology Inc., HORIBA Ltd., Illumina
Inc., Merck KGaA, Olink Holding AB, Perkin Elmer Inc., Promega
Corp., QIAGEN NV, Thermo Fisher Scientific Inc., and Waters
Corp..
Get a detailed analysis on regions, market
segments, customer landscape, and companies- View the
snapshot of this report
Proteomics Market
Scope
|
Report
Coverage
|
Details
|
Base year
|
2023
|
Historic
period
|
2018 - 2022
|
Forecast
period
|
2024-2028
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
16.83%
|
Market growth
2024-2028
|
USD 33999.4
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
14.01
|
Regional
analysis
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
43%
|
Key
countries
|
US, UK, Germany, China,
and Japan
|
Key companies
profiled
|
Agilent Technologies
Inc., Applied Biomics Inc., Bio Rad Laboratories Inc., Biognosys
AG, Bruker Corp., Cell Signaling Technology Inc., CellCarta
Biosciences Inc., Creative Proteomics, DiaSorin Spa, F. Hoffmann La
Roche Ltd., Geno Technology Inc., HORIBA Ltd., Illumina Inc., Merck
KGaA, Olink Holding AB, Perkin Elmer Inc., Promega Corp., QIAGEN
NV, Thermo Fisher Scientific Inc., and Waters Corp.
|
Market Driver
The proteomics market has witnessed notable expansion in recent
years due to the escalating demand for sophisticated diagnostic
tools and personalized medicine. A prominent trend in this sector
is the heightened attention towards monitoring post-translational
modifications (PTMs) of proteins. PTMs are modifications that take
place after a protein is translated from its genetic code. These
alterations can influence a protein's function, activity, and
localization, significantly impacting biological processes. The
identification and quantification of PTMs offer essential insights
into disease mechanisms and pave the way for the development of
targeted therapies. Mass spectrometry is the most widely adopted
method for PTM analysis, enabling the detection and measurement of
multiple PTMs within a single sample. The burgeoning interest in
PTMs has spurred the emergence of new proteomics technologies and
products. Companies are now providing PTM-specific antibodies and
kits for analysis, while there is a growing preference for
high-throughput proteomics techniques like shotgun proteomics to
examine vast numbers of PTMs in a solitary experiment. The emphasis
on PTMs in the proteomics market is anticipated to persist during
the forecast period, fueled by the surging demand for personalized
medicine and the necessity for advanced diagnostic tools to tackle
intricate diseases. This trend will positively influence the
market's growth trajectory.
Proteomics is a rapidly growing market focused on identifying
and understanding proteins and their functions. Key trends include
drug discovery, sensitivity, and resolution in high-throughput
analysis and multiplexed analysis. Data integration and analysis
using informatics tools are essential for biomarker discovery and
personalized medicine. Proteomics research covers protein
functions, disease mechanisms, and protein-protein interactions.
Proteomics technologies include mass spectrometry, protein
profiling, protein interaction analysis, data management, and
various segments like spectroscopy, chromatography,
electrophoresis, protein microarrays, and protein fractionation.
Immunoassay reagents, DNA aptamers, and antibodies are crucial
components. Scalability, reproducibility, and species/sample type
versatility are important considerations. Proteomics aids in
therapeutic target discovery, antibody development, and kinetics
studies using techniques like ELISA sandwich approach and
polyclonal antibodies.
Discover 360° analysis of this market. For
complete information, schedule your consultation - Book
Here!
Market Challenges
• The proteomics
market faces a significant challenge due to a shortage of
adequately trained laboratory professionals. This issue impacts
various sectors of the proteomics industry, including research and
development, manufacturing, and quality control. The root causes of
this shortage are multifaceted. First, there is limited awareness
about proteomics as a field and the career opportunities it
presents, resulting in few students pursuing related studies.
Second, the proteomics industry's rapid advancements necessitate
continuous skill updates for laboratory professionals, which can be
demanding. Lastly, the highly specialized nature of proteomics
makes it difficult to find professionals with the required
expertise for specific projects, leading to hiring and training
costs. Consequently, the lack of recognition for the profession and
insufficient understanding of its importance contribute to the
shortage of skilled personnel, potentially hindering the growth of
the global proteomics market.
• Proteomics,
the study of proteins and their functions, is a rapidly growing
market driven by the need to understand protein-protein
interactions, identify biomarkers for therapeutic targets, and
advance drug development. Challenges include the use of DNA
aptamers for protein binding, scalability and reproducibility in
Proteomics technology, and the complexity of protein biology
research. Key areas of focus are the detection of protein
abundances, variations, and modifications in various species and
sample types. Industry players invest in tools, instruments, and
services such as ELISA sandwich approach, kinetics analysis, and
robotics. Protein microarray, Chromatography, Mass Spectroscopy,
X-ray Crystallography, and Protein fractionation are essential
techniques. The market faces challenges in addressing species and
sample type variations, ensuring accuracy and specificity, and
maintaining these advanced instruments. Funding, awareness, and
healthcare expenditure are crucial factors driving growth.
Nanotechnology and outsourcing are emerging trends. Clinical
diagnosis, genetic disorders, and birth disorders are significant
applications. Key players include Thermo Fisher Scientific, Siemens
Healthineers, and Bio-Rad Laboratories.
For more insights on driver and
challenges - Request a sample report!
Segment Overview
This proteomics market report extensively covers market
segmentation by
- Product
- 1.1 Reagents
- 1.2 Instruments
- 1.3 Services
- End-user
- 2.1 Clinical diagnostics
- 2.2 Drug discovery
- 2.3 Others
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Reagents- The proteomics market refers to the
industry focused on identifying and understanding the functions of
proteins. This field is crucial for drug discovery and development,
diagnostics, and understanding biological processes. Key players
include Thermo Fisher Scientific, Abcam, and Merck KGaA. Growth is
driven by increasing research funding, advancements in technology,
and the rising demand for personalized medicine. Proteomics
techniques, such as mass spectrometry and two-dimensional gel
electrophoresis, are used to analyze protein structures and
functions. Collaborations and acquisitions among market players are
common strategies to expand their offerings and strengthen their
positions.
For more information on market segmentation with
geographical analysis including forecast (2024-2028) and historic
data (2017-2021) - Download a Sample Report
Learn and explore more about Technavio's in-depth research
reports
The global Protein Expression Market is experiencing significant
growth due to increasing demand for biologics and proteomics
research. Key players are investing in advanced technologies to
enhance protein production efficiency.
The global Laboratory Analytical Instruments and Consumables
Market is expanding rapidly, driven by rising R&D activities in
pharmaceuticals, biotechnology, and environmental testing.
Innovative analytical solutions are boosting market growth.
Overall, the global Protein Expression Market and Laboratory
Analytical Instruments and Consumables Market are poised for
substantial growth, driven by technological advancements and
increasing research activities in various sectors.
Research Analysis
Proteomics, a branch of molecular biology that studies proteins,
is a rapidly evolving field that holds great promise for
understanding cellular processes and developing new therapeutics.
Proteomics technology, including DNA aptamers, enables the
large-scale identification and analysis of protein-protein
interactions, biomarkers, therapeutic targets, and variations in
protein abundances and modifications. Proteomics plays a crucial
role in drug development by helping identify interacting partners,
networks, and disease mechanisms. Scalability and reproducibility
are essential in proteomics, with high-throughput analysis and
multiplexed analysis techniques enabling the analysis of thousands
of proteins simultaneously. Data integration and analysis,
including informatics tools, are essential for making sense of the
vast amounts of data generated. Proteomics has applications in
various areas, including the study of cellular processes, genetic
disorders, and birth disorders, and holds potential for
personalized medicine and the discovery of new protein
functions.
Market Research Overview
Proteomics is a rapidly evolving field of molecular biology that
focuses on the large-scale study of proteins, their interactions,
modifications, and functions. Proteomics technology, including DNA
aptamers, mass spectrometry, X-ray crystallography, chromatography,
electrophoresis, protein microarrays, and immunoassays, plays a
crucial role in identifying biomarkers, therapeutic targets, and
understanding protein-protein interactions, cellular processes, and
disease mechanisms. Proteomics research covers various species and
sample types, including human, animal, and microbial samples, and
aims to provide insights into protein abundances, variations,
modifications, and interacting partners, forming networks and
networks involved in cellular processes and genetic disorders.
Proteomics technologies offer high-throughput analysis,
sensitivity, and resolution, enabling personalized medicine and
drug discovery. The industry is driven by awareness, healthcare
expenditure, and funding, with key applications in clinical
diagnosis, laboratory services, and outsourcing. Proteomics
instruments and tools include robotics, nanotechnology, and
informatics tools for data management, analysis, and integration.
The market is segmented into spectroscopy, chromatography,
electrophoresis, protein microarrays, and protein fractionation,
with continuous advancements in technology and techniques.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Product
-
- Reagents
- Instruments
- Services
- End-user
-
- Clinical Diagnostics
- Drug Discovery
- Others
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/proteomics-market-size-is-set-to-grow-by-usd-33-99-billion-from-2024-2028--increasing-advances-in-proteomics-research-boost-the-market-technavio-302195696.html
SOURCE Technavio